StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) operating KPIs

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)

Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%

Gilead Sciences arcus Biosciences — Net income (loss) ($M) ($M)

Arcus Biosciences (RCUS) Form 10-Q / 10-K

QuarterlyAnnual
Latest, Q2 2026
-91
Period ended Jun 30, 2026
Change on a year earlier
–
0 in Q2 2025
History
30 quarters
Since Q1 2019
Sources
10
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedArcus Biosciences — Net income (loss) ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026-91–Arcus Biosciences (RCUS) Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 2026-128+14.3%Arcus Biosciences (RCUS) Form 10-Q (filed 2026-08-05) ↗
Q4 2025Dec 31, 2025-106+12.8%Arcus Biosciences (RCUS) Form 10-K (filed 2026-02-25) ↗
Q3 2025Sep 30, 2025-135+46.7%Arcus Biosciences (RCUS) Form 10-Q (filed 2025-10-28) ↗
Q2 2025Jun 30, 20250-100.0%Arcus Biosciences (RCUS) Form 10-Q (filed 2026-08-05) ↗
Q1 2025Mar 31, 2025-112+2,700.0%Arcus Biosciences (RCUS) Form 10-Q (filed 2026-08-05) ↗
Q4 2024Dec 31, 2024-94+16.0%Arcus Biosciences (RCUS) Form 10-K (filed 2026-02-25) ↗
Q3 2024Sep 30, 2024-92+29.6%Arcus Biosciences (RCUS) Form 10-Q (filed 2025-10-28) ↗
Q2 2024Jun 30, 2024-93+24.0%Arcus Biosciences (RCUS) Form 10-Q (filed 2025-10-28) ↗
Q1 2024Mar 31, 2024-4-95.0%Arcus Biosciences (RCUS) Form 10-Q (filed 2025-10-28) ↗
Q4 2023Dec 31, 2023-81+20.9%Arcus Biosciences (RCUS) Form 10-K (filed 2026-02-25) ↗
Q3 2023Sep 30, 2023-71+9.2%Arcus Biosciences (RCUS) Form 10-Q (filed 2024-11-06) ↗
Q2 2023Jun 30, 2023-75+11.9%Arcus Biosciences (RCUS) Form 10-Q (filed 2024-11-06) ↗
Q1 2023Mar 31, 2023-80+17.6%Arcus Biosciences (RCUS) Form 10-Q (filed 2024-11-06) ↗
Q4 2022Dec 31, 2022-67-124.0%Arcus Biosciences (RCUS) Form 10-K (filed 2025-02-25) ↗
Q3 2022Sep 30, 2022-65-16.7%SEC Filing ↗

Breakdown

What makes up arcus biosciences — net income (loss) ($m)

Cite this data

StockData. (2026). Gilead Sciences Arcus Biosciences — Net income (loss) ($M) ($M), quarterly Q1 2019–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/rcus_net_inc

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.